Dharmini Mehta

418 total citations
12 papers, 342 citations indexed

About

Dharmini Mehta is a scholar working on Molecular Biology, Oncology and Polymers and Plastics. According to data from OpenAlex, Dharmini Mehta has authored 12 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Polymers and Plastics. Recurrent topics in Dharmini Mehta's work include Drug Transport and Resistance Mechanisms (4 papers), Dendrimers and Hyperbranched Polymers (4 papers) and Alzheimer's disease research and treatments (3 papers). Dharmini Mehta is often cited by papers focused on Drug Transport and Resistance Mechanisms (4 papers), Dendrimers and Hyperbranched Polymers (4 papers) and Alzheimer's disease research and treatments (3 papers). Dharmini Mehta collaborates with scholars based in Australia, United States and India. Dharmini Mehta's co-authors include Joseph A. Nicolazzo, Jennifer L. Short, Christopher J. H. Porter, Lisa M. Kaminskas, Cameron J. Nowell, David J. Owen, Victoria M. McLeod, Sarah N. Hilmer, Brian D. Kelly and Markus Müllner and has published in prestigious journals such as Chemical Communications, Journal of Controlled Release and Pharmaceutical Research.

In The Last Decade

Dharmini Mehta

12 papers receiving 341 citations

Peers

Countries citing papers authored by Dharmini Mehta

Since Specialization

Citations

This map shows the geographic impact of Dharmini Mehta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dharmini Mehta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dharmini Mehta more than expected).

Fields of papers citing papers by Dharmini Mehta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dharmini Mehta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dharmini Mehta. The network helps show where Dharmini Mehta may publish in the future.

Co-authorship network of co-authors of Dharmini Mehta

This figure shows the co-authorship network connecting the top 25 collaborators of Dharmini Mehta. A scholar is included among the top collaborators of Dharmini Mehta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dharmini Mehta. Dharmini Mehta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Subcutaneous delivery of a dendrimer-BH3 mimetic improves lymphatic uptake and survival in lymphoma 2022 ·Journal of Controlled Release ·Orlagh M. Feeney, (unknown), Ka Fung Noi, Dharmini Mehta, Robert De Rose, Daniel Yuen, Angus P. R. Johnston, Lee Kingston, Cecilia Ericsson, Charles S. Elmore, Richard Hufton, David J. Owen, Marianne Ashford, Christopher J. H. Porter	10
2	Doxorubicin Conjugation and Drug Linker Chemistry Alter the Intravenous and Pulmonary Pharmacokinetics of a PEGylated Generation 4 Polylysine Dendrimer in Rats 2018 ·Journal of Pharmaceutical Sciences ·(unknown), Dharmini Mehta, Victoria M. McLeod, Brian D. Kelly, Rashmi Pathak, David J. Owen, Christopher J. H. Porter, Lisa M. Kaminskas	13
3	Reducing Dendrimer Generation and PEG Chain Length Increases Drug Release and Promotes Anticancer Activity of PEGylated Polylysine Dendrimers Conjugated with Doxorubicin via a Cathepsin-Cleavable Peptide Linker 2018 ·Molecular Pharmaceutics ·Dharmini Mehta, (unknown), Victoria M. McLeod, Brian D. Kelly, Rashmi Pathak, David J. Owen, Christopher J. H. Porter, Lisa M. Kaminskas	37
4	Lymphatic transport and lymph node targeting of methotrexate-conjugated PEGylated dendrimers are enhanced by reducing the length of the drug linker or masking interactions with the injection site 2017 ·Nanomedicine Nanotechnology Biology and Medicine ·Gemma M. Ryan, Victoria M. McLeod, Dharmini Mehta, Brian D. Kelly, (unknown), David J. Owen, Lisa M. Kaminskas, Christopher J. H. Porter	21
5	Microfluidic preparation of drug-loaded PEGylated liposomes, and the impact of liposome size on tumour retention and penetration 2017 ·Journal of Liposome Research ·(unknown), (unknown), Cameron J. Nowell, Sadık Kağa, (unknown), Dharmini Mehta, Lisa M. Kaminskas, Ben J. Boyd	44
6	Passive tumour targeting and extravasation of cylindrical polymer brushes in mouse xenografts 2016 ·Chemical Communications ·Markus Müllner, Dharmini Mehta, Cameron J. Nowell, Christopher J. H. Porter	31
7	Drug Access to the Central Nervous System in Alzheimer’s Disease: Preclinical and Clinical Insights 2014 ·Pharmaceutical Research ·Dharmini Mehta, Jennifer L. Short, Sarah N. Hilmer, Joseph A. Nicolazzo	34
8	Reduced CNS exposure of memantine in a triple transgenic mouse model of Alzheimer's disease assessed using a novel LC–MS technique 2013 ·Journal of Pharmaceutical and Biomedical Analysis ·Dharmini Mehta, Jennifer L. Short, Joseph A. Nicolazzo	12
9	Altered Brain Uptake of Therapeutics in a Triple Transgenic Mouse Model of Alzheimer’s Disease 2013 ·Pharmaceutical Research ·Dharmini Mehta, Jennifer L. Short, Joseph A. Nicolazzo	61
10	Memantine Transport across the Mouse Blood–Brain Barrier Is Mediated by a Cationic Influx H⁺Antiporter 2013 ·Molecular Pharmaceutics ·Dharmini Mehta, Jennifer L. Short, Joseph A. Nicolazzo	45
11	Melt-in-Mouth Pellets of Fexofenadine Hydrochloride Using Crospovidone as an Extrusion–Spheronisation Aid 2010 ·AAPS PharmSciTech ·(unknown), Dharmini Mehta, Sejal Shah, (unknown), Purnima D. Amin	19
12	Transport of Drugs Across the blood–brain Barrier in Alzheimer‘s Disease 2010 ·Therapeutic Delivery ·Joseph A. Nicolazzo, Dharmini Mehta	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact